SAMP reported a significant 43% YoY increase in full year earnings for CY16, driven mainly by 1) healthy growth in net interest income (+29% YoY), stemming from an expansion in NIM (+0.23ppt YoY) amid strong net loan book growth (+22% YoY); and 2) a 4.3ppt YoY improvement in its cost to income ratio, supported by cost containment measures (such as the introduction of self-deposit kiosks aimed at improving employee productivity) and a ramp up in contribution from newer branches (SAMP almost doubled its branch network over 2008-2014 amid an aggressive expansion drive). We attribute the expansion in SAMP’s NIM - despite a lower CASA ratio - to faster loan re-pricing, as SAMP has 1) a lower-than-peer share of fixed rate term loans in its lending portfolio; and 2) exposure to shorter tenor loan products such as overdrafts and import loans. Loan book growth for the year (+22% YoY) was primarily driven by strong growth in 1) term loans (+34% YoY); 2) overdrafts (+28% YoY); 3) import loans (+15% YoY); 4) housing loans (+26% YoY); and 5) leasing (+19% YoY).
We project full year earnings of Rs. 10.9bn for CY17, translating to an EPS of Rs. 61.70 (+15% YoY). We expect 2017 to be a more difficult year for the sector as a whole, in terms of credit growth as well as continuing pressure on NIMs, with SAMP now offering a rate of 12% on a one year FD amid increased competition for funding across the sector. Our current earnings projection does not factor in the impact of a proposed Financial Transactions Levy (FTL) at the rate of Rs. 5 per Rs.10,000 on total cash transactions. At its current price of Rs. 271.30, SAMP trades at a CY17E P/E of 4.4x and a P/BV of 0.97x , at an unwarranted discount to our banking & finance coverage universe P/E.
•JKSB is one of 15 founding members of the Colombo Stock Exchange with roots in share trading dating back to 1896, and is a subsidiary of John Keells Holdings PLC (JKH), the largest listed entity on the Colombo Stock Exchange with a market capitalization of US$ 1.3bn.
•JKSB’s core client base is Foreign Institutional Investors, Local Institutions and HNWI’s
•JKSB has a co-branded Research tie up with CIMB and a Research Referral agreement with Credit Suisse, along with trade execution relationships with several other global and regional securities firms.
•JKSB’s trade execution partners include Credit Suisse, CIMB, Merrill Lynch, Exotix, Daiwa, Convergex, Deutsche Asia Securities and Morgan Stanley
•JKSB is a research contributor to Bloomberg on ‘KEEL’
•The JKSB Research Universe covers 72 stocks across 15 sectors, with most Research efforts focused on approximately 45 of the more liquid counters.
•The JKSB Universe constitutes 67% of total market cap and approximately 80% of turnover at the CSE.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.